Respiratory syncytial virus (RSV) infects primary neonatal and adult natural killer cells and affects their anti-viral effector function.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
van Erp, Elisabeth AFeyaerts, Dorien
Duijst, Maxime
Mulder, H Lie
Wicht, Oliver
Luytjes, Willem
Ferwerda, Gerben
van Kasteren, Puck B
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Respiratory syncytial virus (RSV) infects primary neonatal and adult natural killer cells and affects their anti-viral effector function.Published in
J Infect Dis 2019; 219(5):723-33Publiekssamenvatting
Respiratory syncytial virus (RSV) is a major cause of severe acute lower respiratory tract infections in infants. Natural killer (NK) cells are important anti-viral effector cells that likely encounter RSV in the presence of virus-specific (maternal) antibodies. Since NK cells potentially contribute to immunopathology, we investigated whether RSV affects their anti-viral effector functions.PMID
30252097ae974a485f413a2113503eed53cd6c53
10.1093/infdis/jiy566
Scopus Count
Collections
Related articles
- <i>In Vitro</i> Enhancement of Respiratory Syncytial Virus Infection by Maternal Antibodies Does Not Explain Disease Severity in Infants.
- Authors: van Erp EA, van Kasteren PB, Guichelaar T, Ahout IML, de Haan CAM, Luytjes W, Ferwerda G, Wicht O
- Issue date: 2017 Nov 1
- Impaired immune response in severe human lower tract respiratory infection by respiratory syncytial virus.
- Authors: Larrañaga CL, Ampuero SL, Luchsinger VF, Carrión FA, Aguilar NV, Morales PR, Palomino MA, Tapia LF, Avendaño LF
- Issue date: 2009 Oct
- Natural killer cell activation by respiratory syncytial virus-specific antibodies is decreased in infants with severe respiratory infections and correlates with Fc-glycosylation.
- Authors: van Erp EA, Lakerveld AJ, de Graaf E, Larsen MD, Schepp RM, Hipgrave Ederveen AL, Ahout IM, de Haan CA, Wuhrer M, Luytjes W, Ferwerda G, Vidarsson G, van Kasteren PB
- Issue date: 2020
- Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease.
- Authors: van Erp EA, Luytjes W, Ferwerda G, van Kasteren PB
- Issue date: 2019
- Broadly Reactive Anti-Respiratory Syncytial Virus G Antibodies from Exposed Individuals Effectively Inhibit Infection of Primary Airway Epithelial Cells.
- Authors: Cortjens B, Yasuda E, Yu X, Wagner K, Claassen YB, Bakker AQ, van Woensel JBM, Beaumont T
- Issue date: 2017 May 15